Press-release for stocks related to vaccine for gsk

| -3.54% | O: 0.41% H: 0.0% C: 0.0%
CSLLY | $90.71 35K

| -4.39% | O: -4.92% H: 3.76% C: 3.44%
GLAXF | News | $19.54 -3.77% 0

| -7.55% | O: -3.4% H: 1.49% C: 1.49%
AZNCF | News | $135.35 400

| 3.22% | O: 1.55% H: 0.82% C: 0.16%
ALPMY | News | $9.47 400K

| -10.83% | O: -1.41% H: 5.06% C: 4.01%
GSK | News | $40.93 0.17% 170K

| -5.29% | O: -0.6% H: 0.19% C: 0.09%
ABT | News | $106.76 -0.12% 150K

| -11.51% | O: 0.26% H: 0.0% C: 0.0%
SNY | News | $46.61 -2.27% -2.21% 220K

| -1.28% | O: 0.57% H: 0.0% C: 0.0%
AZN | News | $75.37 5.86% 2.7M

| 7.07% | O: 1.08% H: 0.82% C: 0.67%
pharma vaccine astrazeneca research key market

Influenza Vaccine Market to grow by USD 2.93 billion from 2022 to 2027; North America to account for 54% of market growth - Technavio
Published: 2023-12-13 (Crawled : 19:00) - prnewswire.com
CMXHF | $176.0 1.59% 0

| -0.86% | O: 5.56% H: 0.71% C: 0.71%
CSLLY | $90.71 35K

| -1.7% | O: 1.46% H: 3.01% C: 0.97%
GLAXF | News | $19.54 -3.77% 0

| 8.35% | O: 0.58% H: 0.0% C: -1.01%
SNYNF | News | $94.0 -0.27% 0

| -2.0% | O: 0.25% H: 0.0% C: 0.0%
AZNCF | News | $135.35 400

| 4.71% | O: 1.19% H: 3.09% C: 1.3%
GSK | News | $40.93 0.17% 170K

| 11.21% | O: 0.76% H: 1.0% C: -0.11%
BAX | $40.35 -1.42% 220K

| 8.77% | O: 1.7% H: 2.44% C: 1.78%
SNY | News | $46.61 -2.27% -2.21% 220K

| -1.77% | O: 0.0% H: 0.0% C: 0.0%
AZN | News | $75.37 5.86% 2.7M

| 8.04% | O: 1.21% H: 0.27% C: -0.52%
america vaccine influenza growth market

Global mRNA Vaccine Market Research Report 2023-2028: COVID-19 Success Opens New Avenues with with 444 Ongoing Clinical Studies Worldwide
Published: 2023-11-08 (Crawled : 03:00) - prnewswire.com
GLAXF | News | $19.54 -3.77% 0

Professional, Scientific, and T...

| 15.01% | O: 1.91% H: 0.0% C: 0.0%
VERV | $6.22 -5.47% 76K

| -64.81% | O: 0.37% H: 0.64% C: -10.76%
GSK | News | $40.93 0.17% 170K

| 16.81% | O: 0.46% H: 0.46% C: -0.23%
MRNA | News S | $105.05 -3.49% 480K

| 47.77% | O: -0.01% H: 0.03% C: -3.14%
CVAC | $2.29 -8.77% 110K

| -54.45% | O: 0.91% H: 1.08% C: -1.44%
BNTX | News | $87.62 -0.53% 29K

| -13.95% | O: 0.13% H: 0.08% C: -2.81%
ARCT 4 | $26.98 -3.4% -3.44% 0

| 37.72% | O: -0.36% H: 0.79% C: -0.61%
covid-19 success report vaccine mrna worldwide ongoing research global market

Global Influenza Vaccine Market Research Report 2023-2028: Shift in Trends towards mRNA-based Flu Vaccine Gaining Momentum
Published: 2023-10-05 (Crawled : 23:00) - prnewswire.com
GLAXF | News | $19.54 -3.77% 0

| 10.28% | O: 0.5% H: 0.0% C: 0.0%
AZNCF | News | $135.35 400

| 0.33% | O: -0.48% H: 1.63% C: -0.57%
GSK | News | $40.93 0.17% 170K

| 13.0% | O: 0.94% H: 0.82% C: 0.41%
SNY | News | $46.61 -2.27% -2.21% 220K

| -12.09% | O: -0.19% H: 0.0% C: 0.0%
AZN | News | $75.37 5.86% 2.7M

| 6.46% | O: 0.24% H: 0.78% C: 0.57%
report vaccine momentum influenza research global trends market

Empowering Healthcare: Global Vaccine Management System Market to Reach $441.17 million by 2028
Published: 2023-08-30 (Crawled : 01:00) - prnewswire.com
GLAXF | News | $19.54 -3.77% 0

| 9.85% | O: -1.57% H: 0.0% C: 0.0%
AZNCF | News | $135.35 400

| -2.7% | O: 0.56% H: 0.0% C: -2.26%
NVS | News | $98.67 0.33% 260K

| -4.77% | O: -0.25% H: 0.47% C: -1.08%
JNJ | News | $147.46 -0.72% 820K

| -10.04% | O: 0.56% H: 0.0% C: 0.0%
GSK | News | $40.93 0.17% 170K

| 15.07% | O: 0.54% H: 0.27% C: -0.59%
SNY | News | $46.61 -2.27% -2.21% 220K

| -12.13% | O: 0.66% H: 0.0% C: 0.0%
AZN | News | $75.37 5.86% 2.7M

| 2.98% | O: 0.46% H: 0.17% C: -0.86%
management vaccine reach global system market

Global Adult Vaccine Market 2023: Rapid Growth in India with Increasing Awareness and Healthcare Measures
Published: 2023-07-28 (Crawled : 22:00) - prnewswire.com
AZN | News | $75.37 5.86% 2.7M

| Email alert Add to watchlist
AZNCF | News | $135.35 400

| Email alert Add to watchlist
SNYNF | News | $94.0 -0.27% 0

| Email alert Add to watchlist
SNY | News | $46.61 -2.27% -2.21% 220K

| Email alert Add to watchlist
GLAXF | News | $19.54 -3.77% 0

| Email alert Add to watchlist
GSK | News | $40.93 0.17% 170K

| Email alert Add to watchlist
vaccine rapid india global growth market

GSK Grants LimmaTech Biologics License to Develop and Commercialize Shigella Vaccine
Published: 2023-07-20 (Crawled : 11:00) - biospace.com/
GSK | News | $40.93 0.17% 170K

| 16.11% | O: 1.19% H: 0.42% C: 0.25%
vaccine license grants

Vaccine research market to grow at a CAGR of 9.88% from 2022 to 2027 | Abbott Laboratories, Astellas Pharma Inc., AstraZeneca Plc, more to emerge as key players- Technavio
Published: 2023-07-14 (Crawled : 11:00) - prnewswire.com
CSLLY | $90.71 35K

| -0.87% | O: -0.54% H: 0.0% C: -1.4%
GLAXF | News | $19.54 -3.77% 0

| 12.46% | O: 0.0% H: 1.42% C: 0.96%
AZNCF | News | $135.35 400

| 1.31% | O: 6.03% H: -2.14% C: -2.14%
ALPMY | News | $9.47 400K

| -34.73% | O: 0.96% H: 0.0% C: -1.71%
GSK | News | $40.93 0.17% 170K

| 17.41% | O: 0.03% H: 0.2% C: -0.8%
ABT | News | $106.76 -0.12% 150K

| -0.79% | O: 0.24% H: 0.44% C: -0.06%
SNY | News | $46.61 -2.27% -2.21% 220K

| -9.66% | O: 0.36% H: 0.0% C: 0.0%
AZN | News | $75.37 5.86% 2.7M

| 5.15% | O: 1.79% H: 0.0% C: -2.23%
pharma vaccine research market

Global Cancer Vaccine Industry Worth $13.4 Billion by 2030: Use of Nanosensors in Diagnosing Cancer Expected to Create Ample Opportunities for Key Players
Published: 2023-06-27 (Crawled : 10:00) - prnewswire.com
GLAXF | News | $19.54 -3.77% 0

| 9.28% | O: -1.1% H: 0.0% C: 0.0%
GSK | News | $40.93 0.17% 170K

| 12.66% | O: -0.91% H: 0.56% C: -0.5%
MRNA | News S | $105.05 -3.49% 480K

| -9.6% | O: 0.03% H: 0.37% C: 0.18%
DVAX | $11.285 -1.18% 110K

| -11.61% | O: 0.08% H: 1.31% C: 0.77%
vaccine expected cancer global

US FDA Approves GSK’s AREXVY, the World’s First Respiratory Syncytial Virus (RSV) Vaccine for Older Adults
Published: 2023-05-03 (Crawled : 23:00) - biospace.com/
GSK | News | $40.93 0.17% 170K

| 12.41% | O: 1.24% H: 1.14% C: 0.11%
AGEN A | $7.425 0.07% 97K

| 426.24% | O: 1.42% H: 6.99% C: 4.2%
fda vaccine respiratory virus

Tetanus toxoid vaccine market to grow at a CAGR of 4.3% from 2021 to 2026: Licensing agreements to drive market growth - Technavio
Published: 2023-04-05 (Crawled : 00:00) - prnewswire.com
CMXHF | $176.0 1.59% 0

| -7.86% | O: 3.84% H: 0.25% C: -1.01%
CSLLY | $90.71 35K

| -8.81% | O: 1.2% H: 0.77% C: 0.67%
GIKLY | $4.4 -3.93% 0

| -8.52% | O: -1.25% H: 0.0% C: 0.0%
GLAXF | News | $19.54 -3.77% 0

| 5.64% | O: -0.21% H: 3.44% C: 3.44%
SNYNF | News | $94.0 -0.27% 0

| -14.55% | O: 1.36% H: 2.91% C: 2.91%
ZTS | $150.63 -0.17% 420K

| -10.0% | O: 0.37% H: 0.44% C: 0.4%
GSK | News | $40.93 0.17% 170K

| 9.11% | O: 0.93% H: 1.08% C: 0.53%
SNY | News | $46.61 -2.27% -2.21% 220K

| -14.07% | O: 1.13% H: 0.0% C: 0.0%
vaccine growth market

Europe Human Papillomavirus Vaccine Market Report 2022: Sector to Reach $1.59 Billion by 2028 at a 4.9% CAGR
Published: 2023-01-27 (Crawled : 01:00) - prnewswire.com
GLAXF | News | $19.54 -3.77% 0

| 14.74% | O: 1.13% H: 1.57% C: 1.57%
GSK | News | $40.93 0.17% 170K

| 15.62% | O: -0.03% H: 0.3% C: -0.08%
SNY | News | $46.61 -2.27% -2.21% 220K

| -3.42% | O: -1.25% H: 0.0% C: 0.0%
europe report vaccine market

Worldwide Vaccines Industry to 2029 - Combination Vaccines Remain a Significant Growth Contributor to Vaccine Spaces
Published: 2023-01-06 (Crawled : 21:00) - prnewswire.com
JNJ | News | $147.46 -0.72% 820K

| Email alert Add to watchlist
GLAXF | News | $19.54 -3.77% 0

| Email alert Add to watchlist
MRNA | News S | $105.05 -3.49% 480K

| Email alert Add to watchlist
GSK | News | $40.93 0.17% 170K

| Email alert Add to watchlist
SNY | News | $46.61 -2.27% -2.21% 220K

| Email alert Add to watchlist
SNYNF | News | $94.0 -0.27% 0

| Email alert Add to watchlist
vaccine growth

North America Human Papillomavirus Vaccine Market to Reach $2.96 Billion by 2028 at a CAGR of 4.7%
Published: 2022-11-30 (Crawled : 19:00) - prnewswire.com
GLAXF | News | $19.54 -3.77% 0

| 20.45% | O: 4.49% H: 4.82% C: 3.08%
SNYNF | News | $94.0 -0.27% 0

| 4.16% | O: 2.64% H: 2.88% C: 2.88%
GSK | News | $40.93 0.17% 170K

| 18.13% | O: 0.61% H: 1.22% C: 0.66%
SNY | News | $46.61 -2.27% -2.21% 220K

| 6.5% | O: 2.96% H: 0.0% C: 0.0%
america vaccine market

$12+ Billion Influenza Vaccines Market to Grow at 7+% CAGR, Globally, by 2028 Lead by Quadrivalent Vaccines Segment with 88.36% Market Share in 2022 | The Insight Partners
Published: 2022-10-28 (Crawled : 11:00) - prnewswire.com
SNYNF | News | $94.0 -0.27% 0

| 12.64% | O: 3.33% H: 0.74% C: -1.67%
GSK | News | $40.93 0.17% 170K

| 24.88% | O: 0.89% H: 1.3% C: 0.79%
SNY | News | $46.61 -2.27% -2.21% 220K

| 13.56% | O: 2.57% H: 0.0% C: 0.0%
MRNA | News S | $105.05 -3.49% 480K

| -24.47% | O: -0.88% H: 5.85% C: 5.69%
influenza market vaccine

Influenza Vaccine Market to grow by USD 2.56 Bn by 2026, Market Segmentation by Type and Geography - Technavio
Published: 2022-10-19 (Crawled : 12:00) - prnewswire.com
CMXHF | $176.0 1.59% 0

| 3.14% | O: -0.59% H: 0.0% C: 0.0%
CSLLY | $90.71 35K

| 4.51% | O: 0.38% H: 0.24% C: -0.31%
AZNCF | News | $135.35 400

| 23.18% | O: -1.21% H: 3.64% C: -0.28%
GSK | News | $40.93 0.17% 170K

| 30.75% | O: 0.96% H: 0.22% C: -0.76%
BAX | $40.35 -1.42% 220K

| -26.38% | O: -0.36% H: 1.95% C: -0.14%
SNY | News | $46.61 -2.27% -2.21% 220K

| 16.97% | O: -1.37% H: 0.0% C: 0.0%
AZN | News | $75.37 5.86% 2.7M

| 27.21% | O: -0.05% H: 0.13% C: -2.56%
vaccine influenza market

Vaccine Research Market to record USD 13.34 Bn growth; Public end-user segment to exhibit high demand -- Technavio
Published: 2022-10-14 (Crawled : 07:00) - prnewswire.com
CMXHF | $176.0 1.59% 0

| 3.75% | O: -0.74% H: 0.0% C: 0.0%
MTLHY | $29.93 -11.69% 1.1K

| 33.26% | O: -2.18% H: 3.41% C: -0.0%
CSLLY | $90.71 35K

| 3.18% | O: -1.43% H: 3.13% C: -0.59%
ALPMF | News | $9.5 1.2K

| -27.76% | O: 2.66% H: 0.0% C: 0.0%
SNYNF | News | $94.0 -0.27% 0

| 24.4% | O: 6.95% H: 0.0% C: 0.0%
AZNCF | News | $135.35 400

| 25.79% | O: 1.95% H: 1.5% C: 1.5%
ALPMY | News | $9.47 400K

| -27.98% | O: 0.46% H: 2.5% C: 0.91%
GSK | News | $40.93 0.17% 170K

| 33.31% | O: 0.59% H: 0.66% C: -0.39%
ABT | News | $106.76 -0.12% 150K

| 4.31% | O: 0.69% H: 0.72% C: -2.2%
SNY | News | $46.61 -2.27% -2.21% 220K

| 21.94% | O: 2.74% H: 0.0% C: 0.0%
AZN | News | $75.37 5.86% 2.7M

| 28.22% | O: 1.22% H: 0.52% C: -2.21%
research vaccine market

Global Pneumococcal Vaccine Market to Reach $11.6 Billion at a CAGR of 5.32%
Published: 2022-10-05 (Crawled : 19:00) - prnewswire.com
ALPMF | News | $9.5 1.2K

| -30.71% | O: -0.95% H: 0.0% C: 0.0%
GLAXF | News | $19.54 -3.77% 0

| 30.29% | O: -2.53% H: 0.0% C: 0.0%
ALPMY | News | $9.47 400K

| -30.77% | O: -1.24% H: 0.07% C: -0.59%
GSK | News | $40.93 0.17% 170K

| 34.36% | O: -1.25% H: 0.53% C: -0.1%
SNY | News | $46.61 -2.27% -2.21% 220K

| 19.69% | O: -1.63% H: 0.0% C: 0.0%
global vaccine market pneumococcal

USD 28.28 Bn growth expected in Vaccines Market -- Driven by increased funding for vaccine development and new vaccine launches
Published: 2022-09-28 (Crawled : 09:00) - prnewswire.com
CMXHF | $176.0 1.59% 0

| -3.96% | O: -0.61% H: 0.0% C: 0.0%
MTLHY | $29.93 -11.69% 1.1K

| 28.15% | O: 1.63% H: 0.0% C: -0.48%
CSLLY | $90.71 35K

| -1.15% | O: -0.43% H: 1.81% C: 1.44%
GLAXF | News | $19.54 -3.77% 0

| 38.33% | O: 1.05% H: 4.0% C: 4.0%
AZNCF | News | $135.35 400

| 27.09% | O: 2.35% H: 0.0% C: -0.68%
ALPMY | News | $9.47 400K

| -27.82% | O: -1.91% H: 2.64% C: 1.94%
GSK | News | $40.93 0.17% 170K

| 42.57% | O: 1.12% H: 2.14% C: 1.66%
SNY | News | $46.61 -2.27% -2.21% 220K

| 26.59% | O: 0.83% H: 0.0% C: 0.0%
AZN | News | $75.37 5.86% 2.7M

| 33.73% | O: 0.04% H: 3.14% C: 2.68%
vaccine expected funding growth market

Global $12.27 Bn Influenza Vaccines Markets, 2022-2028: Strong Pipeline Candidates & Opportunities in Emerging Economies
Published: 2022-09-09 (Crawled : 12:00) - prnewswire.com
GLAXF | News | $19.54 -3.77% 0

| 32.25% | O: -1.6% H: 6.13% C: 6.13%
SNYNF | News | $94.0 -0.27% 0

| 23.26% | O: 4.47% H: 0.0% C: 0.0%
GSK | News | $40.93 0.17% 170K

| 29.67% | O: 1.4% H: 0.06% C: -0.19%
SNY | News | $46.61 -2.27% -2.21% 220K

| 19.09% | O: 2.11% H: 0.0% C: 0.0%
MRNA | News S | $105.05 -3.49% 480K